Indian pharmaceutical industry welcomes U.S. tariff exemption, boosting stock prices and reinforcing commitment to affordable, quality medicines.

Pharma-connected shares traded higher after US President Donald Trump imposed a 27 % reciprocal tariff’ on India, exempting ...

Other names on the Nifty Pharma index that has a significant upside potential include Aurobindo Pharma and Ajanta Pharma, both of which have an upside potential of 23%.

The exemption given to Indian pharmaceuticals is positive and, therefore, this segment is likely to witness buying, says ...

Indian pharma stocks surge as generic drugmakers exempted from U.S. tariff, boosting Nifty Pharma shares and industry outlook ...

It’s a party for pharma stocks on Dalal Street. The Nifty Plarma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA ...

Pharma stocks surge after US exempts products from tariffs, Nifty Pharma and healthcare indices show positive gains.

Shares of Indian pharma companies with significant US exposure surged by up to 14% after President Trump refrained from ...

AM, all 20 Nifty Pharma constituents traded in the green. Among others, Gland Pharma was up 7.74 per cent, Lupin was up over ...

Natco Pharma has announced the supperannuation of Tummala Venkata Rao, Vice President - Production of the Company."With ...

Ganesh Dongre of Anand Rathi recommends three stocks to buy or sell on Tuesday — Container Corporation of India (Concor), ...